Sonoma pharmaceuticals to exhibit at medica 2024 in dÜsseldorf

Boulder, co / accesswire / october 31, 2024 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn ® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it will be exhibiting at medica 2024 in dÜsseldorf, germany november 11-14, 2024. medica is considered the largest and most prestigious medical trade fair in the world, expected to attract over 120,000 visitors from more than 70 countries and over 5,300 exhibitors, showcasing the latest innovations in medical technology, diagnostics, and healthcare it.
SNOA Ratings Summary
SNOA Quant Ranking